Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Patient Registry at the Neurosurgery Department

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01628406
First received: June 21, 2012
Last updated: May 27, 2016
Last verified: May 2016
  Purpose

The investigators record all indications, treatments and outcomes from patients treated at the Neurosurgery Department.

  • Trial with surgical intervention

Condition Intervention Phase
Patients Treated at the Neurosurgery Department
Procedure: Treatment at the neurosurgery departement
Phase 1

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: A Patient Registry at the Neurosurgery Department.

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • neurological outcome [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    validated scales like KPSS or NIHSS

  • social outcome [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    e.g. activity of daily living, employment status


Estimated Enrollment: 12000
Study Start Date: June 2012
Estimated Study Completion Date: August 2022
Estimated Primary Completion Date: August 2022 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients treated at the neurosurgery department
Patients treated at the neurosurgery department
Procedure: Treatment at the neurosurgery departement
Treatment at the neurosurgery departement

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients treated at the Neurosurgery Department
Criteria

Inclusion criteria:

All patients treated at the Neurosurgery Department

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01628406

Locations
Switzerland
University Hospital Zurich, Neurosurgery
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Johannes Sarnthein, MD University Hospital Zurich, Division of Neurosurgery
  More Information

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01628406     History of Changes
Other Study ID Numbers: 122 
Study First Received: June 21, 2012
Last Updated: May 27, 2016
Health Authority: Switzerland: UZurich

ClinicalTrials.gov processed this record on December 02, 2016